UPDATED
·
4 Min Read

What are pharmacy benefit managers (PBMs) and why we need reform?

PBM reform focuses on increasing transparency, ensuring savings reach patients and maintaining fair access to medications.

Access to Care

Your powerful ally

The AMA helps physicians build a better future for medicine, advocating in the courts and on the Hill to remove obstacles to patient care and confront today’s greatest health crises.

Empty tablet blister pack
·
5 Min Read

Drug shortages affect 88% of primary care physicians

Newly published AMA survey findings underscore the disruption and severe impact of shortages on physician practices—and patient outcomes. 

Behavioral Health
·
5 Min Read

Jan. 9, 2026: National Advocacy Update

Telehealth flexibilities for prescribing controlled substances extended and more in the latest National Advocacy Update.

Advocacy Update
Physician or health care professional reviewing patient lab results on a computer desktop
UPDATED
·
3 Min Read

Addressing and managing drug shortages

The AMA has declared drug shortages to be an urgent public health crisis. Stay informed and access resources to address the impacts on practice.

Federal Advocacy
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Dec. 22, 2025

In the news: Similar genetics may drive multiple psychiatric conditions, FDA approves oral semaglutide pill, COVID-19 may have link to chronic conditions and more.

Publications & Newsletters
UPDATED
·
2 Min Read

Consumer-driven health care: Council on Medical Service reports

Download PDFs of key council reports that advance policies that emphasize patient choice and control of their health care by addressing high-value care, retail/store-based clinics, addiction treatment centers, genetic/genomic precision medicine, telemedicine, insurance coverage options, reference pricing, prescription drugs, and hospital care coordination.

Medical Service
UPDATED
·
2 Min Read

Drug coverage & spending: Council on Medical Service reports

Download PDFs of council reports that have proposed strategies to address high and escalating prescription drug prices and costs, including promoting transparency and pharmaceutical market competition, combating anti-competitive practices, and outlining criteria for value-based pricing and prescription drug importation.

Medical Service
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Oct. 27, 2025

In the news: Stillbirths more common in U.S. than previously reported, GLP-1s show promise in treating substance use disorders and more. 

Publications & Newsletters
·
6 Min Read

Oct. 31, 2025: National Advocacy Update

FDA issues new guidance aimed at speeding biosimilar time to market and lower costs, and more in the latest National Advocacy Update.

Advocacy Update